| Title |
A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study
|
|---|---|
| Published in |
Vascular Health and Risk Management, May 2014
|
| DOI | 10.2147/vhrm.s64038 |
| Pubmed ID | |
| Authors |
Mohamed Hassanein, Khalifa Abdallah, Anja Schweizer |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 187 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 1% |
| Denmark | 1 | <1% |
| Unknown | 184 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 27 | 14% |
| Student > Master | 22 | 12% |
| Researcher | 18 | 10% |
| Other | 13 | 7% |
| Student > Doctoral Student | 10 | 5% |
| Other | 33 | 18% |
| Unknown | 64 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 60 | 32% |
| Nursing and Health Professions | 22 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 6% |
| Agricultural and Biological Sciences | 4 | 2% |
| Biochemistry, Genetics and Molecular Biology | 4 | 2% |
| Other | 17 | 9% |
| Unknown | 68 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2022.
All research outputs
#15,810,483
of 26,017,215 outputs
Outputs from Vascular Health and Risk Management
#446
of 815 outputs
Outputs of similar age
#129,338
of 245,848 outputs
Outputs of similar age from Vascular Health and Risk Management
#12
of 25 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 815 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 245,848 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.